0001104659-22-027327.txt : 20220225 0001104659-22-027327.hdr.sgml : 20220225 20220225162654 ACCESSION NUMBER: 0001104659-22-027327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211025 FILED AS OF DATE: 20220225 DATE AS OF CHANGE: 20220225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cotliar Jonathan CENTRAL INDEX KEY: 0001886791 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39727 FILM NUMBER: 22680503 MAIL ADDRESS: STREET 1: C/O LIFESCI ACQUISITION II CORP. STREET 2: 250 W 55TH STREET, #3401 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Science 37 Holdings, Inc. CENTRAL INDEX KEY: 0001819113 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 844278203 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 600 CORPORATE POINTE STREET 2: SUITE 320 CITY: CULVER CITY STATE: CA ZIP: 90230 BUSINESS PHONE: (984)377-3737 MAIL ADDRESS: STREET 1: 600 CORPORATE POINTE STREET 2: SUITE 320 CITY: CULVER CITY STATE: CA ZIP: 90230 FORMER COMPANY: FORMER CONFORMED NAME: Lifesci Acquisition II Corp. DATE OF NAME CHANGE: 20200723 4 1 tm227777-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-10-25 0 0001819113 Science 37 Holdings, Inc. SNCE 0001886791 Cotliar Jonathan 800 PARK OFFICES DRIVE, SUITE 3606 RESEARCH TRIANGLE PARK NC 27709 0 1 0 0 Chief Medical Officer Common Stock 2021-10-25 4 M 0 4538 0.85 A 539879 D Common Stock 2021-10-25 4 M 0 5857 0.85 A 545736 D Common Stock 2021-10-28 4 M 0 68074 0.40 A 613810 D Common Stock 2021-12-02 4 M 0 977 0.85 A 614787 D Common Stock 2021-12-02 4 M 0 11345 0.40 A 626132 D Stock Option 0.85 2021-10-25 4 M 0 4538 0 D 2027-08-01 Common Stock 4538 0 D Stock Option 0.85 2021-10-25 4 M 0 5857 0 D 2028-03-07 Common Stock 5857 4882 D Stock Option 0.40 2021-10-28 4 M 0 68074 0 D 2029-06-18 Common Stock 68074 226920 D Stock Option 0.85 2021-12-02 4 M 0 977 0 D 2028-03-07 Common Stock 977 3905 D Stock Option 0.40 2021-12-02 4 M 0 11345 0 D 2029-06-18 Common Stock 11345 215575 D Stock Option was fully vested and exercisable as of the date of the transaction. Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the vesting date. Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date. The total amount has been adjusted to add eight derivative securities that were not previously included due to a rounding error. Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the applicable vesting date. Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date. /s/ Christine Pellizzari, Attorney-in-Fact for Jonathan Cotliar 2022-02-25